PMSA 2025 Annual Conference

Join Our Track Session

Breakout 9B: Revolutionizing Pharma Commercial through Gen AI

Date & Time: Wednesday, May 21st 2025 at 09:30 AM ET to 10:00 AM ET (30mins)

Generative AI (GenAI) is rapidly transforming the pharmaceutical commercialization landscape by enabling greater personalization, operational efficiency, and data-driven decision-making. As traditional sales models lose effectiveness and market dynamics become more complex, GenAI stands out as a game-changer—capable of generating tailored text, images, and videos to address the evolving needs of patients, payers, and HCPs. Agilisium’s GenAI-powered solutions are built to help commercial teams extract actionable insights, develop highly targeted marketing assets, and enhance engagement through intelligent bots, agents, and virtual assistants. However, the true power of GenAI depends on access to high-quality data. In a sector where real-world data is often fragmented or restricted, Agilisium leverages advanced synthetic data generation techniques—such as statistical modeling, GANs, VAEs, agent-based modeling, and differential privacy—to fill data gaps and unlock the full potential of GenAI. Our purpose-built solutions for life sciences accelerate MLR approvals, summarize documents for faster decision-making, generate global field medical insights, and even reduce the time required to develop clinical trial documentation, ultimately driving faster and smarter commercialization in a highly regulated industry.